ADJUVANT CANCER PEPTIDE VACCINE TREATMENT WITH INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Obara, Wataru
Hara, Isao
Miki, Tsuneharu
Mimata, Hiromitsu
Shuin, Taro
Fujioka, Tomoaki
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.1585
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP56-17
引用
收藏
页码：E570 / E570
页数：1
相关论文
共 50 条
  • [41] Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
    Serretta, Vincenzo
    Sommatino, Francesco
    Gesolfo, Cristina Scalici
    Franco, Vito
    Cicero, Giuseppe
    Allegro, Rosalinda
    UROLOGY ANNALS, 2015, 7 (01) : 21 - 25
  • [42] DETECTION OF CIRCULATING TUMOUR CELLS AS PROGNOSTIC FACTOR IN INTRAVESICAL ADJUVANT THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
    De Berardinis, Ettore
    Busetto, Gian Maria
    Antonini, Gabriele
    Di Placido, Mariarosaria
    Nicolazzo, Chiara
    Petracca, Arianna
    Gentile, Vincenzo
    Gazzaniga, Paola
    ANTICANCER RESEARCH, 2010, 30 (04) : 1426 - 1427
  • [43] Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
    Pak, Sahyun
    Kim, Sun-Young
    Kim, Sung Han
    Joung, Jae Young
    Park, Weon Seo
    Chung, Jinsoo
    Lee, Kang Hyun
    Seo, Ho Kyung
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] A genome-wide association study on intravesical recurrence after BCG therapy for non-muscle invasive bladder cancer
    Nagakawa, Shohei
    Shiota, Masaki
    Fujimoto, Naohiro
    Yamamoto, Yoshiaki
    Tsukahara, Shigehiro
    Matsumoto, Takashi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Uchiumi, Takeshi
    Matsuyama, Hideyasu
    Eto, Masatoshi
    CANCER SCIENCE, 2022, 113 : 1588 - 1588
  • [45] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [46] THE OUTCOME OF THE INTRAVESICAL BCG TREATMENT IN NAIVE POSITIVE TUBERCULIN SKIN TEST NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Shusit, P.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 285 - 285
  • [47] Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment
    Gabriela R. Passos
    Juliana A. Camargo
    Karen L. Ferrari
    Mário J. A. Saad
    Amilcar C. de Mattos
    Leonardo O. Reis
    Medical Oncology, 2018, 35
  • [48] Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer
    Bree, Kelly K.
    Brooks, Nathan A.
    Kamat, Ashish M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 513 - 529
  • [49] Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer
    Weizer, Alon Z.
    Tallman, Christopher
    Montgomery, Jeffrey S.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (01) : 59 - 71
  • [50] Predictive factors and influence of intravesical therapy for recurrence of non-muscle invasive bladder cancer
    Garcia-Rodriguez, Jorge
    Fernandez Gomez, Jesus Maria
    Gonzalez Alvarez, Roberto Carlos
    Jalon Monzon, Antonio
    Regadera Sejas, Javier
    Martin Benito, Jose Luis
    SALUD I CIENCIA, 2009, 17 (03): : 247 - 251
12345